
The upcoming gathering in Brussels aims to strengthen European policies that promote adult immunisation, emphasizing that people living with non‑communicable illnesses still receive too few preventive shots despite clear advantages.
The fifth edition of #VaccinAction will bring together leaders from patient advocacy organisations and civil‑society networks. It follows a recent European Commission consultation on the EU Cardiovascular Health Plan, during which the Active Citizenship Network‑Cittadinanzattiva urged the integration of preventive inoculations.
Evidence shows that protecting adults with chronic conditions is cost‑effective, yet it is rarely placed high on health agendas. Those with long‑term illnesses such as heart disease face amplified danger from infections, and the meeting will examine how preventive shots can lower complication rates.
Civil‑society coalitions have long pressed the bloc to align health strategies with patient priorities. This session intends to amplify that influence, offering a platform where experts share successful advocacy examples.
During the programme, presenters will unveil case studies that illustrate how targeted campaigns have shifted policy, while attendees collaborate to craft communication tools that spread the message throughout Europe.
Unlike childhood programmes, adult inoculation often lacks a sense of immediacy, even when data confirm it prevents severe outcomes. Organisers will call for clearer bloc guidelines, though it remains uncertain whether legislators will act promptly. For the moment, patient groups are framing the approach as a direct method to reduce hospital stays and enhance long‑term wellbeing.
The focus on chronic disease marks a broader evolution: preventive measures are no longer confined to infectious‑disease control. For individuals managing ongoing health issues, routine shots can translate into fewer flare‑ups and an improved quality of life.
Ensuring that European policies keep pace with this shift constitutes the central challenge. The network’s previous achievements suggest momentum, yet converting that energy into formal regulation will still demand sustained effort.
Participants will depart equipped with practical resources to advocate for change, but the ultimate test lies in whether member states will translate recommendations into action. The network’s history indicates readiness, though persistence remains essential.
Patient organisations continue to present immunisation as a straightforward strategy to cut hospitalisations and boost long‑term health outcomes.
